Item 7.01 Regulation FD Disclosure
On
The information in this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section, nor shall it be deemed subject to the requirements of amended Item 10 of Regulation S-K, nor shall it be deemed incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language in such filing. The furnishing of this information hereby shall not be deemed an admission as to the materiality of any such information.
Safe Harbor Statement
This report includes "forward-looking statements" within the meaning of the
Securities Litigation Reform Act of 1995. These statements include but are not
limited to the Company's plans, objectives, expectations and intentions and may
contain words such as "will," "may," "seeks," and "expects," that suggest future
events or trends. These statements, the Company's ability to generate the growth
in its core business, develop and grow an international recurring business
model, the Company's ability to develop social media marketing campaigns, and
the Company's ability to build a leading franchise in dermatology and
aesthetics, are based on the Company's current expectations and are inherently
subject to significant uncertainties and changes in circumstances. Actual
results may differ materially from the Company's expectations due to financial,
economic, business, competitive, market, regulatory, adverse market conditions
or supply chain interruptions resulting from the corona virus and political
factors or conditions affecting the Company and the medical device industry in
general, as well as more specific risks and uncertainties set forth in the
Company's
© Edgar Online, source